Latest News

February 3, 2024

ECOG-ACRIN pays tribute to Edith Mitchell, MD

February 2, 2024

Edith P. Mitchell, health-care trailblazer, civil rights pioneer, and retired Air Force brigadier general, has died at 76 (obituary, The Philadelphia Inquirer)

February 1, 2024

Nomination Period Now Open: 2024 Remarkable Mentor to Women in Oncology Award (deadline March 7)

January 29, 2024

Edith Mitchell, medical oncologist, champion of health equity, and brigadier general, dies at 76 (obituary, The Cancer Letter)

January 22, 2024

Statement by Drs. O’Dwyer and Schnall on the passing of Edith Mitchell, MD

January 22, 2024

The Winter 2024 advocacy blog Considering Clinical Trials is now available

January 17, 2024

Press Release: ECOG-ACRIN research team led by Michael Atkins, MD receives Journal of Clinical Oncology 2023 Paper of the Year

January 16, 2024

Attention Fellows: Applications are being accepted for the 2024 Paul Carbone, MD Fellowship Award (apply by February 22)

January 16, 2024

Nomination Period Now Open: 2024 Young Investigator Award (deadline February 22)


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
41

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group